LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced sides effects, in vivo.

Authors

F. J. Lopez
R. J. Ardecky
B. Bebo
K. Benbatoul
L. De Grandpre

Document Type

Journal Article

Publication Date

2008

Journal

Endocrinology

Volume

149

Issue

5

Inclusive Pages

2080-2089

APA Citation

Lopez, F., Ardecky, R., Bebo, B., Benbatoul, K., & De Grandpre, L. (2008). LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced sides effects, in vivo.. Endocrinology, 149 (5). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs/2633